Author

Andy Conery

Institution: Constellation Pharmaceuticals (United States)

Observed institution: Constellation Pharmaceuticals (United States)

OpenAlex ID: A5042698102

RBBP4-p300 axis modulates expression of genes essential for cell survival and is a potential target for therapy in glioblastoma

2022 · Ann C Mladek, Huihuang Yan, et al. · Neuro-Oncology · 29

EXTH-12. INHIBITION OF CBP/p300 HISTONE ACETYLATION ACTIVITY ENHANCES TEMOZOLOMIDE ACTIVITY IN GLIOBLASTOMA PATIENT DERIVED XENOGRAFTS

2020 · Gaspar J Kitange, Danielle M Burgenske, et al. · Neuro-Oncology

Abstract B179: Mechanism of antitumor activity of BET inhibitors in models of lymphomas and leukemia.

2011 · Peter Sandy, Jennifer Mertz, et al. · Molecular Cancer Therapeutics

Works count: 3

Citation count: 29

H-index: 1

I10-index: 1